Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. SCHLX: which is better?

Bottom line

XLV vs SCHLX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 81% by weight.

XLV is cheaper at 0.08% vs 1.06% — a difference of $98 a year per $10,000 invested.

Updated Nov 19, 2026

XLV vs SCHLX side by side

XLVSCHLX
TypeETFMutual fund
Fund familySPDR (State Street)DWS (Xtrackers)
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%1.06%
Annual cost per $10k$8$106
10-yr cost on $10k (prospectus)$103$1,294
Max front loadNone0%
12b-1 fee0.02%0%
1-yr return+14.5%—
5-yr return (annualized)+8.1%—
10-yr return (annualized)+9.8%—
Best quarter+14.5%—
Worst quarter−12.7%—
Net assets (fund)$40.6B$231.8M
Number of holdings6565
Portfolio turnover2%2%
Returns as ofDec 31, 2025—

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

21 of XLV's top 25 holdings also appear in SCHLX's top 25.

Shared top holdings
HoldingXLVSCHLX
Eli Lilly & Co16.51%13.85%
Johnson & Johnson10.64%6.19%
AbbVie Inc7.74%4.90%
UnitedHealth Group Inc6.57%5.73%
Merck & Co Inc5.52%4.85%
Amgen Inc3.40%2.88%
Thermo Fisher Scientific Inc3.24%3.46%
Abbott Laboratories2.75%2.39%
Gilead Sciences Inc2.73%2.78%
Intuitive Surgical Inc2.45%2.69%
Pfizer Inc2.39%1.17%
Vertex Pharmaceuticals Inc2.19%2.45%
Danaher Corp2.09%2.13%
Bristol-Myers Squibb Co2.05%1.50%
Stryker Corp1.89%2.61%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

SCHLX top 10

  1. Eli Lilly & Co — 13.85%
  2. Johnson & Johnson — 6.19%
  3. UnitedHealth Group Inc — 5.73%
  4. AbbVie Inc — 4.90%
  5. Merck & Co Inc — 4.85%
  6. AstraZeneca PLC — 3.80%
  7. Thermo Fisher Scientific Inc — 3.46%
  8. Novartis AG — 2.90%
  9. Amgen Inc — 2.88%
  10. Gilead Sciences Inc — 2.78%

FAQ

What is the difference between XLV and SCHLX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 81% by weight. XLV is cheaper at 0.08% vs 1.06% — a difference of $98 a year per $10,000 invested.
Which is cheaper, XLV or SCHLX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and SCHLX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.